American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th edition, text revision). Washington DC: American Psychiatric Association, 2000.
2.
HorvathKStefanatosGSokolskiKNWachtelRNaborsLTildonJT. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. Journal of the Association for Academic Minority Physicians1998; 9: 9–15.
3.
SandlerADSuttonKADeWeeseJGirardiMASheppardVBodfishJW. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. New England Journal of Medicine1999; 341: 1801–1806.
4.
ChezMGBuchananCPBaganBTHammerMSMcCarthyKSOvrutskayaI. Secretin and autism: A two part clinical investigation. Journal of Autism and Developmental Disorders2000; 30: 87–94.
5.
SponheimEOftedalGHelverschouSB. Multiple doses of secretin in the treatment of autism: A controlled study. Acta Paediatrica2002; 91: 540–545.
6.
KernJKVan MillerSEvansPATrivediMH. Efficacy of porcine secretin in children with autism and pervasive developmental disorder. Journal of Autism and Developmental Disorders2002; 32: 153–160.
7.
Dunn-GeierJ. Effect of secretin on children with autism: A randomized controlled trial. Developmental Medicine & Child Neurology2000; 42: 796–802.
8.
McQueenJMHeckAM. Secretin for the treatment of autism. Annals of Pharmacotherapy2002; 36: 305–311.
